
MSC - F. Surgery Answers 2025
.pdf
Others:
Proctosigmoidoscopy (if tolerated or under anesthesia) – to rule out internal opening or secondary pathology (e.g., tumor, Crohn's)
Treatment:
Surgical intervention is mandatory – no role for antibiotics alone.
Principles of Surgery:
1.Immediate Incision and Drainage (I&D):
Under general anesthesia
Radial or semilunar incision over the point of maximal tenderness or fluctuation
Adequate drainage must be ensured
2.Eliminate Internal Opening (if identified):
Only in subcutaneous paraproctitis – Gabriel's operation (simultaneous drainage + internal opening excision)
In other types: dealt with later during definitive surgery for fistula
3.Special Cases:
Horseshoe abscess (posterior, bilateral): requires bilateral semilunar incisions (Fig. 22)
Postoperative Care:
Sitz baths
Stool softeners, laxatives
Analgesics
Broad-spectrum antibiotics (if systemic signs of infection or immunocompromised)

Complications:
Chronic fistula-in-ano (in 70–75% if internal opening not addressed)
Sepsis (if delayed treatment)
Recurrence
Incontinence (if sphincter injured)
13.Anaerobic paraproctitis: features of the clinic, diagnosis and treatment.
Definition:
A rapidly progressive, necrotizing infection of the perirectal tissues caused by anaerobic bacteria, characterized by tissue destruction, sepsis, and high mortality.
Most severe form of paraproctitis
Mortality rate: 10–30% or higher
More common in males
Strong association with diabetes mellitus and immunosuppression
Etiology:
Caused by anaerobic organisms, both:
Clostridial: Clostridium perfringens (gas gangrene-like features)
Non-clostridial: Bacteroides, Fusobacterium, Peptostreptococcus, etc.
Predisposing factors:
Diabetes mellitus
Immunosuppression (HIV, malignancy, corticosteroids)
Local trauma or surgical manipulation
Chronic perianal infections

Pathogenesis:
Entry through anal crypts or existing fissures/abscesses
Rapid spread due to low oxygen tension in perianal tissues
Toxin production → tissue necrosis, vascular thrombosis, systemic toxicity
Gas formation in tissues (esp. clostridial infections)
Impaired host immunity allows rapid anaerobic proliferation
Forms (3 clinical types):
1.Putrefactive form – less aggressive; localized necrosis
2.Progressive gangrenous form – extensive necrosis and soft tissue destruction (similar to Fournier’s gangrene)
3.Anaerobic lymphangitis – lymphatic spread with systemic sepsis
Clinical Presentation:
Early Stage:
Sudden onset of severe perianal pain
High fever (38–40°C)
Tachycardia, chills, malaise
Perineal fullness, pressure Advanced Stage (3–7 days):
Rapidly spreading edema, erythema, and crepitus
Necrosis of skin, subcutaneous fat, fascial planes (perineum, genitalia, thighs)
Foul-smelling discharge and gas in tissues
Systemic toxicity: hypotension, septic shock
Grave general condition

Diagnosis:
Clinical Examination:
Signs of necrotizing soft tissue infection (NSTI) in perineum
Blackish or purplish skin, blistering, discharge of gas and pus
Palpable crepitus (subcutaneous gas)
Rectal exam: pain, bogginess (done only if tolerated)
Laboratory:
Leukocytosis, anemia, hypoproteinemia
Elevated CRP, procalcitonin
Lactate ↑, metabolic acidosis
Microbiology:
Gas-liquid chromatography, microscopy of smears for early detection
Culture and sensitivity (takes 5–7 days)
Imaging (if time permits before surgery):
CT scan: shows gas in soft tissues, abscess pockets, fascial spread
MRI: delineates deep fascial involvement (if not contraindicated by time)
Treatment:
This is a surgical emergency. Delay = death.
1.Surgical Management (Immediate):
Wide surgical debridement under general anesthesia
Semilunar or radial incisions to:
o Drain abscess
o Remove all necrotic tissue

oDecompress fascial compartments
Repeat wound inspections/debridements may be required
If thigh involvement: additional incisions to track and drain fascial extensions
2.Antimicrobial Therapy:
Empiric high-dose, broad-spectrum antibiotics with anaerobic coverage:
oMetronidazole (obligatory)
o Piperacillin-tazobactam, carbapenems, or cefoperazone-sulbactam
oVancomycin (if MRSA risk)
Adjust based on culture
3.Antifungal Prophylaxis (especially in diabetics):
Fluconazole or Ketoconazole to prevent secondary fungal infections
4.Local Wound Care:
Modern antiseptics
Polyethylene glycol-based ointments
Hydrocolloid dressings, polyurethane foam
Aerosol applications
Use of:
oUltrasonic cavitation
o Low-intensity laser therapy
oOzonized irrigation
5.Supportive Therapy:
Disintoxication: IV fluids, vasopressors if needed

Hyperbaric oxygen therapy (HBO) – reduces anaerobic proliferation, enhances healing
Blood UV irradiation (controversial)
Immunocorrection
Control of comorbidities (e.g., strict glycemic control in diabetics)
Prognosis:
Mortality is high without prompt, aggressive treatment
With early surgery + antibiotics, survival improves
Long-term sequelae: anal deformity, fistula, incontinence
14.Chronic paraproctitis: Concept, etiopathogenesis, clinical picture.
Definition:
Chronic paraproctitis is a long-standing inflammation of the pararectal tissue, typically developing as a complication of inadequately treated or undrained acute paraproctitis, leading to the formation of a fistulous tract (fistula in ano).
Etiopathogenesis:
Primary cause: Failure to resolve acute anal abscess, resulting in persistent suppuration
Infectious flora: Mixed aerobes and anaerobes
Mechanism:
oCryptoglandular infection → formation of abscess → incomplete drainage → persistent tract between anal crypt and skin
Fistula components:
oInternal orifice (in anal canal)
o Tract (fibrous, often surrounded by granulation tissue)

o External orifice (on perianal skin)
Clinical Picture:
Intermittent purulent or mucous discharge from external opening
Recurrent perianal pain, worse with defecation
Pruritus, skin maceration, occasional fecal/gas leak
Fever and malaise during exacerbations
The disease has a chronic undulating course: periods of remission interrupted by exacerbations
15.Chronic paraproctitis: classification, diagnosis and treatment.
Classification of Rectal Fistulas (By Parks, modified):
1.By anatomical relationship to sphincter: o Intersphincteric
o Transsphincteric o Suprasphincteric o Extrasphincteric
o Submucosal/subcutaneous (simpler, low-lying fistulas)
2.By tract orientation:
oAnterior / Posterior / Lateral
3.By complexity:
oSimple – low, single tract
oComplex – high, branching, multiple tracts, or associated with IBD, TB, or malignancy
4.By activity:
oActive (suppurating) vs. inactive (healed or epithelialized)

Diagnosis:
Clinical:
Purulent or serous discharge from a perianal opening
Palpable indurated tract
Pain during defecation or at rest in acute phases
Physical Examination:
Inspection of perianal region for external opening
Digital rectal exam: Palpate tract or induration
Fistula probing: To map tract (done carefully to avoid creation of false passage)
Instrumental:
Proctosigmoidoscopy: Identifies internal orifice, rules out other rectal pathology
Fistulography: Contrast study for complex/extrasphincteric fistulas
MRI pelvis: Gold standard in complex, recurrent, or Crohn’s-related fistulas
Endoanal ultrasound: Maps fistula path relative to sphincters
Sphincterometry: Measures sphincter tone (pre-op planning)
Treatment:
Conservative therapy is ineffective in achieving cure. Surgery is the definitive treatment.
Surgical Options (Based on Fistula Type):
1.Intersphincteric Fistulas:
Gabriel's operation (simple fistulectomy) o Excision of tract

o Internal opening is removed
oHealing by secondary intention
2.Low Transsphincteric Fistulas:
Gabriel’s operation with partial division and primary closure of sphincter fibers
3.High Transsphincteric & Extrasphincteric Fistulas (Complex):
Seton placement: Loose or cutting
Ligation of intersphincteric fistula tract (LIFT)
Advancement flap: Internal orifice is closed with a mucosal/submucosal flap
Fibrin glue, fistula plug: Biologic therapies (limited success)
4.Horseshoe or Multiple Fistulas:
Multiple incisions, drainage, fistulotomy or staged procedures
High risk of incontinence; sphincter-sparing strategies preferred
Postoperative Care:
Sitz baths, hygiene
Analgesia
Fiber-rich diet and stool softeners
Antibiotics if signs of infection or systemic symptoms
Wound dressing
Complications:
Recurrence (1–4%)
Anal incontinence (1–4%, depending on complexity and technique)
Delayed wound healing

Prognosis:
Excellent in intersphincteric/simple fistulas
Guarded in complex/extrasphincteric fistulas
Recurrence and sphincter damage risk increases with multiple surgeries or improper techniques
16.Epithelial coccygeal cyst: etiology, pathogenesis, clinic, diagnosis and treatment.
1. Epithelial Coccygeal Cyst (Pilonidal Disease)
Definition:
An epithelial coccygeal cyst, also known as a pilonidal sinus, is a congenital or acquired epithelial tract in the sacrococcygeal region, typically located midline in the intergluteal cleft, with one or more primary openings. It may remain asymptomatic or progress to inflammation, abscess formation, or chronic fistulous disease.
Etiology:
Congenital theory: Embryological epithelial invagination or remnant of the medullary canal.
Acquired theory (dominant modern view):
oHair penetration into subcutaneous tissue causes foreign body reaction.
oRisk factors:
Hirsutism
Obesity
Sedentary lifestyle
Deep natal cleft and poor hygiene